Aquilo Capital Management, LLC
SAN FRANCISCO, CA · CIK 1591986 · 13F filing filed 2024-02-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Legal entityAQUILO CAPITAL MANAGEMENT, LLC (US)
- Others nearbySan Francisco, CA
$142.6m
reported value
+29.2% vs Q3 2023
9positions
100.0%in top 10
2 new
1 added
4 reduced
5 sold out
vs Q3 2023
Options: 0 call positions (— notional), 1 put positions ($17.9m notional) – listed below, not included above.
Holdings, Q4 2023
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARROWHEAD PHARMACEUTICALS IN ARWR | $27.8m19.50% | Unchanged |
| BLUEPRINT MEDICINES CORP BPMC | $23.5m16.48% | Reduced -124.3k |
| KYMERA THERAPEUTICS INC KYMR | $22.4m15.74% | Added +99.1k |
| ARVINAS INC ARVN | $20.1m14.12% | Unchanged |
| SILENCE THERAPEUTICS PLC SLN | $18.1m12.71% | Reduced -268.9k |
| REGENXBIO INC RGNX | $14.4m10.10% | Reduced -45.0k |
| MERUS N V MRUS | $9.8m6.85% | Reduced -75.0k |
| REPARE THERAPEUTICS INC RPTX | $4.6m3.24% | New |
| SUTRO BIOPHARMA INC COM | $1.8m1.27% | New |
Sold out since Q3 2023
| Security | Value then |
|---|---|
| C4 THERAPEUTICS INC CCCC | $3.7m2.0m shares |
| GENMAB A/S GMAB | $1.8m52.1k shares |
| ARGENX SE ARGX | $1.8m3.7k shares |
| OLEMA PHARMACEUTICALS INC OLMA | $1.1m88.9k shares |
| PIERIS PHARMACEUTICALS INC | $984.4k3.3m shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR SER TR XBI · Put | $17.9m200.0k shares | New |